India Drug Delivery Devices Market By Devices (Syringe, Inhaler, Nebulizer, Transdermal Patch), By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Others), By Application (Cancer, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Others), By End User (Hospitals, Diagnostic Centres, Ambulatory Surgery Centres, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

India Drug Delivery Devices Market was valued at USD 12.70 Billion in 2024 and is expected to reach USD 18.05 Billion by 2030 with a CAGR of 6.11% during the forecast period. The Drug Delivery Devices Market encompasses the global industry dedicated to the development and sales of medical devices specifically designed to deliver medications and therapeutic agents into the body in a controlled manner. These devices play a crucial role in the treatment of a wide range of illnesses and diseases, offering a diverse range of options from simple syringe systems to cutting-edge nanotechnology systems. With various segments based on the route of administration, including oral, injectable, topical, ocular, nasal, and pulmonary, this market caters to the specific needs of patients across different medical domains. Technological advancements continue to drive innovation in drug delivery devices, enabling more precise and targeted treatment options for patients. The increased prevalence of chronic diseases and the growing geriatric population are significant factors contributing to the growth of this market. As the demand for effective and convenient drug delivery solutions continues to rise, the Drug Delivery Devices Market remains a dynamic and evolving sector within the healthcare industry.

Key Market Drivers

Rising Prevalence of Chronic Diseases

India is witnessing a significant rise in the prevalence of chronic diseases, including diabetes, heart disease, and cancer. This surge has created an urgent need for efficient and effective drug delivery devices that can cater to the growing healthcare demands. Given the long-term management required for most of these diseases, the demand for drug delivery devices that ensure precise and targeted medication administration has witnessed a substantial upsurge.

Drug delivery devices, such as insulin pens, inhalers, and pre-filled syringes, play a crucial role in empowering patients to self-administer medication. This aspect becomes particularly critical considering India's vast population and the potential shortage of healthcare professionals. The increasing popularity of home healthcare services has further fueled the demand for these devices, as they provide convenience and accessibility to patients in the comfort of their own homes. The rising awareness about various chronic diseases and the importance of maintaining a strict medication regime for effective disease management has contributed to the escalating demand for drug delivery devices. Recognizing this need, both the government and healthcare companies are working collaboratively to enhance the accessibility and affordability of these devices, thereby promoting their widespread use among the affected population.

In a nutshell, the escalating prevalence of chronic diseases in India is directly influencing the surge in demand for drug delivery devices, and this trend is expected to persist in the foreseeable future. The continuous efforts towards improving access and affordability will further drive the adoption of these devices, ensuring better disease management and improved quality of life for the affected individuals.

Technological Advancements in the Medical Device Manufacturing

Technological advancements in medical device manufacturing are revolutionizing the landscape of drug delivery devices in India. With the introduction of smart, connected, and miniaturized drug delivery devices, the demand has surged, particularly in chronic disease management. These advanced devices ensure precise and controlled drug dispensation, enhancing treatment outcomes and patient compliance. The COVID-19 pandemic has accelerated the adoption of telemedicine and remote healthcare, further fueling the demand for these devices. Through remote monitoring, patients and healthcare providers can effectively track medication adherence and measure treatment effectiveness, making healthcare more efficient and accessible. In addition, India's growing middle class, increasing healthcare expenditure, and government initiatives to boost domestic medical device manufacturing are contributing to the rising demand. This surge in demand not only addresses India's current healthcare challenges but also sets the stage for a future where every individual has access to effective and personalized healthcare.

By leveraging technological innovation in the medical device sector, India is not only transforming its healthcare system but also creating opportunities for improved healthcare delivery and better health outcomes for all.

Rapid Growth of The Biopharmaceutical Industry

The biopharmaceutical industry in India is experiencing unprecedented growth, driven by several factors. One key driver is India's positioning as a hub for affordable biopharmaceutical production, attracting significant domestic and international investment. This has led to the establishment of state-of-the-art manufacturing facilities and research centers, fostering innovation and driving the development of novel drug therapies.

Another contributing factor to the industry's growth is the rise in chronic diseases in India, coupled with an aging population. As the prevalence of diseases such as diabetes, cardiovascular disorders, and respiratory conditions continues to increase, there is an urgent need for effective drug delivery systems. Patient-centric devices, including inhalers, injectors, and controlled-release implants, play a crucial role in ensuring the efficient and precise administration of medication. These devices not only improve therapeutic impact but also enhance patient compliance, ultimately leading to better health outcomes.

The ongoing innovation in biopharmaceuticals necessitates parallel advancements in drug delivery technology. With the development of complex biological drugs, such as monoclonal antibodies and gene therapies, there is a growing demand for sophisticated delivery systems that can safely and effectively transport these therapies to their intended targets. This requires the integration of advanced materials, monitoring technologies, and smart delivery mechanisms into drug delivery devices. Therefore, the rapid growth of the biopharmaceutical industry in India is undeniably linked to the escalating demand for drug delivery devices. As the industry continues to expand and evolve, there will be a continuous need for innovative and reliable drug delivery solutions that can meet the evolving requirements of patients and healthcare professionals.

Rising Investments by The Drug Manufacturers In The Clinical Trials

India's booming pharmaceutical industry has been making substantial investments in clinical trials, further amplifying the demand for cutting-edge drug delivery devices within the country. The introduction of innovative drug delivery systems, including inhalers, transdermal patches, and insulin pens, serves as a testament to the industry's commitment to revolutionize healthcare. These novel devices hold immense potential to augment the efficacy of drug administration, rendering treatments more user-friendly and significantly improving patient compliance.

The ongoing investments in clinical trials by drug manufacturers not only underscore their unwavering dedication to enhancing healthcare outcomes but also play a pivotal role in ensuring the safety and efficacy of new drug delivery devices before they are introduced to the market. This unwavering commitment to research and development showcases the industry's determination to prioritize patient well-being. The influx of investments in India's pharmaceutical sector not only signifies its remarkable growth potential but also emphasizes the urgent need to update and enhance drug delivery mechanisms. These transformative developments are poised to pave the way for groundbreaking, effective, and patient-centric solutions, thereby fueling the demand for advanced drug delivery devices across the nation.

The significant strides made in drug delivery technologies are a testament to the pharmaceutical industry's unwavering dedication to providing superior healthcare management. As investments continue to flow into clinical trials, the market for drug delivery devices in India is poised for exponential growth in the coming years. This rapid evolution in drug delivery mechanisms holds the key to a brighter and healthier future for all.

Download Free Sample Report

Key Market Challenges

High Risk of Needlestick Injuries

Despite the increased need for effective drug delivery devices in India, there is a growing concern over the high risk of needlestick injuries that is impacting the demand negatively. Needlestick injuries pose a significant risk to healthcare personnel, potentially leading to the transmission of blood-borne pathogens, including HIV, Hepatitis B, and Hepatitis C. This risk factor is especially relevant in a densely populated country like India, where the healthcare system is often under pressure and safety protocols may not always be strictly adhered to.

The fear of needlestick injuries is leading to a hesitancy in the adoption of drug delivery devices, with many individuals preferring oral medication or non-invasive treatment options instead. This shift in preference is causing disruptions in the market growth of drug delivery devices in India. To address this ongoing issue, it is crucial to develop safer and more secure delivery systems that can regain consumer confidence and meet the demand effectively. By implementing advanced safety features and ensuring strict adherence to safety protocols, the development of such delivery systems can mitigate the risks associated with needlestick injuries. This, in turn, will help to restore consumer trust and drive the demand for drug delivery devices in India.

Lack of Awareness About Drug Delivery Devices

The demand for Drug Delivery Devices (DDD) in India is currently experiencing a significant downturn. This trend can be attributed to a general lack of awareness about these devices, especially among people residing in rural and semi-urban areas. Many individuals remain largely uninformed about the existence, usage, and numerous benefits of DDDs. These innovative devices are specifically designed to deliver drugs into the human body in a controlled and precise manner, thus enhancing the treatment of various medical conditions. However, due to the absence of adequate knowledge and understanding, potential users continue to rely on traditional methods of drug intake, which in turn reduces the demand for sophisticated drug delivery systems.

The problem is further compounded by inadequate marketing strategies and insufficient training of healthcare professionals. This lack of promotion and education contributes to the prevailing unawareness surrounding DDDs. To reverse this concerning trend, it is crucial to initiate extensive awareness campaigns about DDDs, targeting both consumers and healthcare providers. These campaigns should emphasize the immense benefits of using these devices for effective drug administration, ensuring that individuals are well-informed and empowered to make informed decisions about their healthcare. By increasing awareness and understanding, we can pave the way for a greater adoption of DDDs and improve the overall quality of healthcare delivery in India.

Key Market Trends

Increasing Funding from Government & Private Organization

In India, the demand for drug delivery devices has experienced a significant surge in recent years. This surge can be attributed to several factors, including a substantial increase in funding from both government and private organizations. These organizations have recognized the vital role that drug delivery devices play in enhancing the efficiency of drug administration and improving patient outcomes. Government initiatives, such as the National Health Mission (NHM) and Ayushman Bharat, have been instrumental in driving this growth. These initiatives have not only increased their investment in healthcare infrastructure and technologies but have also prioritized the development and acquisition of innovative drug delivery devices. As a result, healthcare providers across the country have witnessed an influx of funding, which has not only bolstered the availability of these devices but has also facilitated extensive research and development efforts.

Private organizations, including large pharmaceutical companies and health-focused NGOs, have also played a significant role in this landscape. These organizations have recognized the importance of investing in advanced drug delivery systems and have allocated substantial resources to support their development and acquisition. This collaborative effort between the public and private sectors has led to the introduction of more advanced and effective delivery systems, meeting the evolving needs of healthcare providers and patients alike. The overall effect of this funding surge is a rapid increase in demand for drug delivery devices in India. As healthcare providers strive to offer the best possible care to their patients, they are increasingly relying on these devices to ensure accurate and efficient drug administration. This growing demand not only reflects the commitment of healthcare providers to deliver optimal care but also highlights the transformative impact that advanced drug delivery devices can have on patient outcomes.

Innovative Strategies Adopted by The Key Market Players

Innovative strategies adopted by key market players in India are significantly driving the demand for drug delivery devices. These companies are not only focusing on research and development, but they are also investing in cutting-edge technologies to introduce new and improved devices. These devices aim to provide effective, safe, and patient-friendly methods of drug delivery. For instance, the implementation of drug-eluting stents has been transformative in improving patient outcomes in cardiovascular conditions. These stents release medication to the affected area, reducing the risk of complications and enhancing the effectiveness of treatment. Similarly, the rise in insulin pens has revolutionized the management of diabetic conditions. These pens offer a convenient and precise way to administer insulin, improving patient compliance and overall diabetes management.

Collaborations and partnerships have become a prevailing trend in the industry. This has led to enhanced technological exchange and product portfolio expansion. Companies are joining forces to leverage their strengths and resources, resulting in the development of more advanced and diverse drug delivery devices. To ensure accessibility to advanced healthcare, companies are strategically targeting rural areas. They are focusing on providing affordable and user-friendly devices that can be easily used by healthcare professionals in these areas. This effort aims to bridge the healthcare gap between urban and rural regions, making essential treatments more accessible to all.

The introduction of digitized devices and telemedicine services has created a paradigm shift in the industry. These innovations offer remote patient monitoring and adherence tracking, providing real-time data to healthcare providers. This not only improves patient care but also helps in identifying any potential issues or complications early on. These advancements in drug delivery devices have not only heightened patient trust but have also demonstrated treatment efficacy. The expanded market reach has resulted in the growth of drug delivery devices in India, making significant contributions to the healthcare industry and improving the overall quality of patient care.

Segmental Insights

Route of Administration Insights

Based on Route of Administration, the Injectable drug delivery emerged as the fastest growing segment in the Indian market for Drug Delivery Devices during the forecast period. Chronic diseases such as diabetes, cancer, autoimmune disorders, and cardiovascular conditions are increasingly prevalent in India. These conditions often necessitate long-term management with medications that are unsuitable for oral administration due to issues like low bioavailability or degradation in the gastrointestinal tract. A growing number of biologic therapies, including monoclonal antibodies, insulin, and vaccines, require injectable delivery to ensure their effectiveness. These therapies have significantly advanced the treatment of chronic diseases and are being more widely adopted in India.

The introduction of user-friendly self-injection devices, such as pen injectors and auto-injectors, has made injectable treatments more accessible, enabling patients to administer their own medications at home, which improves compliance and convenience. For instance, insulin pens have become increasingly popular among diabetes patients. Additionally, innovations like needle-free injectors using high pressure to deliver medication through the skin are helping to mitigate discomfort and fear associated with injections, driving greater acceptance.

Injectable drugs offer more targeted delivery, directly administering the medication to the bloodstream or specific areas in the body, which is especially beneficial for localized treatments such as cancer or rheumatoid arthritis. Furthermore, controlled-release formulations allow for the gradual release of drugs, reducing the need for frequent dosing and enhancing patient compliance. There is a growing trend toward personalized medicine and the use of biologic therapies, which often require injectable delivery. Injectable medications often require fewer doses or are available in sustained-release forms, which can lead to improved patient compliance and better health outcomes for chronic conditions. As India’s pharmaceutical market continues to expand, many companies are focusing on injectable formulations to meet both domestic and international demand. India’s emerging role as a manufacturing hub for biologics and injectables has further expanded the market for these products.

Application Insights

Based on application, the diabetes emerged as the dominating segment in the Indian market for Drug Delivery Devices in 2024. This is due to the sustained rise in population, coupled with improvements in healthcare infrastructure and accessibility, has led to a larger pool of individuals seeking medical attention and preventive measures. This demographic shift underscores the importance of addressing chronic conditions like diabetes, which require ongoing management and treatment. The increasing disposable income among consumers has enabled greater spending on healthcare and wellness products. As people prioritize their health and well-being, they are more inclined to invest in technologies and solutions that aid in the effective management of chronic diseases like diabetes. This trend is particularly evident in emerging economies where rising affluence is translating into greater healthcare expenditure. The sustained growth trajectory of the diabetes segment underscores the pressing need to address diabetes as a public health priority. Governments, healthcare providers, and industry stakeholders are recognizing the importance of investing in preventive measures, early diagnosis, and effective management strategies to mitigate the burden of diabetes on individuals and healthcare systems alike.

Download Free Sample Report

Regional Insights

Based on region, West India emerged as the dominating region in India Drug Delivery Devices Market in 2024. This dominance can be attributed to the high concentration of reputable pharmaceutical companies, supported by a robust healthcare infrastructure and substantial investments in cutting-edge research and development activities within these states. The region's strategic geographical location, favorable government policies, and well-established supply chain networks contribute significantly to its prominence in the market. In Maharashtra, for example, the city of Mumbai serves as a key hub for pharmaceutical manufacturing and research, housing numerous renowned pharmaceutical companies and research institutions. The state's well-developed healthcare infrastructure, with top-notch hospitals and medical facilities, ensures a conducive environment for the development and adoption of advanced drug delivery devices.

Gujarat, on the other hand, boasts a strong pharmaceutical presence with a wide range of pharmaceutical companies operating in the state. The government's proactive approach in promoting research and development, along with attractive incentives for pharmaceutical companies, has further bolstered the state's position as a major player in the drug delivery devices market. The Western region's strategic geographical location plays a crucial role in its prominence within the market. Situated on the western coast of India, it provides convenient access to both domestic and international markets, facilitating efficient distribution and export of drug delivery devices. The region benefits from well-established supply chain networks, ensuring smooth and timely delivery of products to healthcare providers and end-users.

Recent Development

• In August 2024, a multi-institutional team led by researchers from IIT Bhilai, in collaboration with scientists from Shiv Nadar Institution and Shri Rawatpura Sarkar Institute of Pharmacy, Chhattisgarh, successfully developed an innovative insulin delivery platform. This hydrogel-based drug delivery system is designed to release insulin in a controlled manner in response to elevated blood glucose levels, mimicking the natural insulin secretion process of healthy pancreatic cells. The study, led by Dr. Suchetan Pal, Assistant Professor in the Department of Chemistry at IIT Bhilai, offers a promising, safe, and efficient solution for insulin-dependent diabetic patients.
• In April 2024, Dr. Reddy’s Laboratories Ltd. announced the launch of Nerivio, a non-invasive wearable device for migraine management, in Germany through its step-down subsidiary Betapharm. This marks the company’s entry into the European digital therapeutics market. Nerivio is approved by the U.S. Food and Drug Administration (USFDA) and is CE-mark certified in Europe. The device was launched in India by Dr. Reddy’s in 2023 and is supported by the company’s unique patient support program, ‘M-Free,’ in the country. Additionally, Dr. Reddy’s entered into an exclusive agreement with Theranica, a digital therapeutics company specializing in advanced neuromodulation devices for migraine and other pain conditions, to market and distribute Nerivio across multiple markets.
• In March 2024, the Union Minister for Chemicals & Fertilizers and Health & Family Welfare virtually launched 27 greenfield bulk drug park projects and 13 greenfield medical device manufacturing plants under the PLI Scheme. The PLI scheme aims to facilitate the production of 41 bulk drugs with a total investment of USD 820.10 Million over the scheme’s duration from 2020-21 to 2029-30. Additionally, 26 applicants for medical device manufacturing have been approved for 138 products under the scheme, with a total financial allocation of USD 404.14 Million for the period 2020-21 to 2027-28.

Key Market Players

• Pfizer Ltd.
• Novartis India Ltd.
• GlaxoSmithKline Pharmaceuticals Ltd.
• India Medtronic Private Ltd.
• Cardinal Health International India Pvt Ltd.
• B. Braun Medical (India) Pvt. Ltd.
• Sun Pharmaceutical Industries Ltd.
• 3M India Ltd.
• Cipla Ltd.
• Bayer Zydus Pharma

Report Scope:

In this report, the India Drug Delivery Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Drug Delivery Devices Market, By Devices:

o   Syringe

o   Inhaler

o   Nebulizer

o   Transdermal Patch

• India Drug Delivery Devices Market, By Route of Administration:

o   Oral Drug Delivery

o   Injectable Drug Delivery

o   Topical Drug Delivery

o   Others

• India Drug Delivery Devices Market, By Application:

o   Cancer

o   Respiratory Diseases

o   Diabetes

o   Cardiovascular Diseases

o   Others

• India Drug Delivery Devices Market, By End User:

o   Hospitals

o   Diagnostic Centres

o   Ambulatory Surgery Centres

o   Others

• India Drug Delivery Devices Market, By Region:

o   North

o   South

o   West

o   East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Drug Delivery Devices Market.

Available Customizations:

India Drug Delivery Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

India Drug Delivery Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]